Category: News

  • Glaston’s financial reports in 2023

    Glaston Corporation will disclose the following financial reports in 2023: Financial Statement Bulletin 2022, on Thursday, 9 February 2023 Interim report January-March 2023, on Wednesday, 26 April 2023 Half year financial report January-June 2023, on Tuesday, 1 August 2023 Interim report January-September 2023, on Thursday, 26 October 2023 Glaston’s Financial Statements 2022 and Annual Report 2022 […]

  • Lynparza approved in EU for early breast cancer

    AstraZeneca and MSD’s Lynparza (olaparib) has been approved in the European Union (EU) as monotherapy or in combination with endocrine therapy for the adjuvant treatment of adult patients with germline BRCA1/2 mutations (gBRCAm), who have human epidermal growth factor receptor 2 (HER2)-negative high-risk early breast cancer previously treated with neoadjuvant or adjuvant chemotherapy.   This approval by […]